Evidence map›Paper›PMID 38176736›Full record

Observational studyRMD open2024

History of pre-eclampsia does not appear to be a risk factor for vascular phenotype in women with systemic sclerosis.

Claire De Moreuil, Elizabeth Diot, Christian Agard, Nicolas Belhomme, Alain Lescoat, Viviane Queyrel, Nathalie Tieulie, Marie-Elise Truchetet, Grégory Pugnet, Sabine Berthier and 14 more

Open access · goldAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in RMD open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 100% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 13 institutions in 1 country.

Claire De MoreuilInternal Medicine, Vascular Medicine and Pneumology Department, Brest University Hospital, Brest, France claire.demoreuil@chu-brest.fr.ORCID 0000-0003-1142-0978
Elizabeth DiotInternal Medicine, Regional University Hospital Centre Tours, Tours, France.
Christian AgardInternal Medicine, Nantes University Hospital, Nantes, France.
Nicolas BelhommeDepartment of Internal Medicine and Clinical Immunology, Rennes University Hospital, Rennes, France.
Alain LescoatDepartment of Internal Medicine and Clinical Immunology, Rennes University Hospital, Rennes, France.
Viviane QueyrelInternal Medicine, Nice Cote d'Azur University, Nice, France.
Nathalie TieulieRheumatology, Pasteur Hospital, Nice University Hospital, Nice Sophia Antipolis University, Nice, France.
Marie-Elise TruchetetRheumatology, Bordeaux University Hospital, Bordeaux, France.ORCID 0000-0001-8045-0180
Grégory PugnetINSERM UMR1027, Toulouse, France.
Sabine BerthierInternal Medicine, Bocage Hospital, Dijon, France.
Perrine SmetsInternal Medicine Department, Centre Clermont-Ferrand University Hospital, Clermont-Ferrand, France.
Benjamin SubranInternal Medicine Department, La Croix Saint-Simon Hospital, Paris, France.
Olivier LidoveInternal Medicine Department, La Croix Saint-Simon Hospital, Paris, France.
Jeremy KeraenInternal Medicine, Hospital Centre Cornouaille, Quimper, France.
Arsène MekinianInternal Medicine, DHUi2B, Saint Antoine Hospital, AP HP, Université Pierre et Marie Curie, Paris, France.ORCID 0000-0003-2849-3049
Emmanuel ChatelusRheumatology, Strasbourg University Hospital, Strasbourg, France.
Elisabeth PasquierInternal Medicine, Vascular Medicine and Pneumology Department, Brest University Hospital, Brest, France.
Emilie BrenautDermatology, Brest University Hospital, Brest, France.
Bénedicte RouvièreUMR1227, Lymphocytes B et Autoimmunité, Université de Brest, INSERM, CHU de Brest, Brest, France.
Mathieu DelplanqueInternal Medicine, Vascular Medicine and Pneumology Department, Brest University Hospital, Brest, France.
Sandy LucierCIC 1412, INSERM, Brest University Hospital, Brest, France.
Emmanuelle Courtois-CommunierCIC 1412, INSERM, Brest University Hospital, Brest, France.
Valérie Devauchelle-PensecRheumatology, Brest University Hospital, Brest, France.
Eric HachullaInternal Medicine Department, Centre de Référence des Maladies Auto-immunes Systémiques Rares Du Nord et Nord-Ouest de France, Lille, France.
Inserm · FRCentre Hospitalier Régional Universitaire de Brest · FRGroupe Hospitalier Diaconesses Croix Saint-Simon · FRInstitut de Recherche en Santé, Environnement et Travail · FRCentre Hospitalier de Cornouaille · FRCentre Hospitalier Universitaire de Clermont-Ferrand · FRCentre Hospitalier Universitaire de Tours · FRInstitut de Chimie de Nice · FRNantes Université · FRSorbonne Université · FRUniversité Côte d'Azur · FRUniversité de Strasbourg · FRUniversité Lille Nord de France · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVascular phenotype is associated with a poor prognosis in systemic sclerosis (SSc). The identification of its risk factors could facilitate its early detection.

objectivesTo explore risk factors for a vascular phenotype of SSc, among them a history of pre-eclampsia.

methodsThis observational multicentre case-control study enrolled adult women fulfilling European Alliance of Associations for Rheumatology 2013 diagnosis criteria for SSc and having a pregnancy history≥6 months before SSc diagnosis in 14 French hospital-based recruiting centres from July 2020 to July 2022. Cases had specific vascular complications of SSc defined as history of digital ischaemic ulcers, pulmonary arterial hypertension, specific cardiac involvement or renal crisis. Women with SSc were included during their annual follow-up visit and filled in a self-administered questionnaire about pregnancy. A case report form was completed by their physician, reporting data on medical history, physical examination, clinical investigations and current medication. The main outcome was the presence/absence of a personal history of pre-eclampsia before SSc diagnosis, according to the validated pre-eclampsia questionnaire.

results378 women were included: 129 cases with a vascular phenotype and 249 matched controls. A history of pre-eclampsia was reported in 5 (3.9%) cases and 12 (4.8%) controls and was not associated with a vascular phenotype (OR=0.96, 95% CI 0.28 to 3.34, p=0.9). Besides, Rodnan skin score and disease duration≥5 years were risk factors for vascular phenotype.

conclusionsIn women with SSc and a pregnancy history≥6 months before SSc, a history of pre-eclampsia is not associated with a vascular phenotype.

Indexed as

Pre-EclampsiaScleroderma, SystemicAdultCase-Control StudiesFemaleHumansPhenotypePregnancyRisk FactorsSkin UlcerAntibodies, AntiphospholipidAutoimmune DiseasesClassificationEpidemiologyScleroderma, Systemic

Identifiers

PMID38176736
PMCPMC10773441
OpenAlexW4390631518

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.